Thyrotoxicosis and Atrial Fibrillation
Abstract
Thyrotoxicosis is a clinical syndrome caused by the effect of excess thyroid hormones on the body. The term “hyperthyroidism” is also used to describe this syndrome - a state of hyperproduction of thyroid hormones by the thyroid gland, both pathological and physiological (for example, during pregnancy). The frequency of detection of hyperthyroidism in patients with atrial fibrillation (AF), according to various authors, ranges from 5 to 63% and depends on many factors: the age and gender of the patients, the initial state of the cardiovascular system and thyroid gland, the treatment, and also on the severity iodine deficiency in the region where the subjects live.
References
Berestennikova L.N., Chumakova G.A., Timofeev A.V. The influence of thyroxine on the course of atrial fibrillation in patients without thyrotoxicosis. Current issues in medicine: a collection of scientific papers / Municipal Institution “City Hospital No. 1”. Barnaul, 2007, p.67-68.
Bystrova T.V., Troshina E.A., Abdulkhabirova F.M. State of the cardiovascular system in subclinical thyrotoxicosis. Diseases of the heart and blood vessels. 2006, 1 (3), pp.51-53.
Gerasimov G.A., Fadeev V.V., Sviridenko N.Yu., Melnichenko G.A., Dedov I.I.. Iodine deficiency diseases in Russia. A simple solution to a complex problem. M.; Adamant, 2002.- 168 p.
Gratiy K.F., Grossu A.A., Kuzor T.S., Chenusha O.V. Features of atrial fibrillation in patients with hyperfunction of the thyroid gland. Cardiovascular therapy and prevention. 2008, 7(6), Appendix 1, p.98.
Diagnosis and treatment of atrial fibrillation. Russian recommendations. Supplement to the journal "Cardiovascular Therapy and Prevention". 2005. - 28 p.
Clinical recommendations. Endocrinology / ed. I.I. Dedova, G.A. Melnichenko. - M.: GEOTAR Media, 2007. - 304 p.
Leinova E.V., Khokhlov A.L., Buidina T.A. Changes in parameters of the cardiovascular system in patients with thyrotoxicosis depending on age and duration of course. Cardiovascular therapy and prevention. 2008, 7(6), Appendix 1, p. 215-216.
Miller O.N., Skurikhina O.N., Starichkov S.A. The use of class IC drugs in patients with atrial fibrillation associated with arterial hypertension and chronic heart failure with preserved systolic function. Russian Journal of Cardiology. 2008, 4 (72).
Radzevich A.E., Konyakhin A.Yu., Kameneva T.R. and others. The place of etacizin in the treatment of atrial fibrillation. Cardiologist. 2005, No. 1, pp. 1-7.
Sviridenko N.Yu., Platonova N.M., Molashenko N.V. Thyroid dysfunction when taking amiodarone. Problems of endocrinology. 2002, vol. 48, no. 2, pp. 22-27.
Sviridenko N.Yu., Platonova N.M., Molashenko N.V. and others. Conditions caused by taking amiodarone in the practice of a cardiologist and endocrinologist. Attending doctor. 2004, no. 2, pp. 16-20.
Serdyuk S.E., Bakalov S.A., Soboleva V.A. and others. Amiodarone-associated thyroid dysfunction: frequency of development, possibilities of correction. BULLETIN OF ARRHYTHMOLOGY, No. 56, 2009 Cardiology. 2004, No. 10, pp. 33-38.
Serdyuk S.E., Bakalov S.A., Golitsyn S.P. and others. Thyroid dysfunction during long-term use of amiodarone. Relationship between the antiarrhythmic effectiveness of amiodarone and the effect of the drug on thyroid function. Cardiology. 2005, No. 1, pp. 22-27.
Tavrovskaya T.V., Shatillo K.G., Likh N.A. et al. Newly diagnosed atrial fibrillation: characteristics of patients. Cardiovascular therapy and prevention. 2007, 6 (5), Appendix 1, p. 299. 15. Whitman E. Etiology, diagnosis and treatment of Graves’ disease // Thyroid International.-2003, No. 2, pp. 3-15.
Fadeev V.V., Melnichenko G.A. Hypothyroidism (a guide for doctors). - M., RKI Severopress, 2002.
Fadeev V.V. Diagnosis and treatment of toxic goiter. Russian medical journal. 2002, volume 10, no. 11 (155), p. 513 - 516.
Fadeev V.V. Graves' disease. Russian medical journal. 2002, volume 10, no. 27 (171) - P.1262-1265.
Fadeev V.V. Thyroid nodules: international algorithms and domestic clinical practice. Doctor. 2002, No. 7, pp. 12-16.
Fadeev V.V. Pathogenetic therapy of euthyroid goiter. Consilium medicum. 2002. Volume 4. No. 10, pp. 516-520.
Fadeev V.V. TSH level standards: are changes needed? Clinical essay. Clinical thyroidology.2004, No. 3, pp. 5-9.
Chazov E.I., Dedov I.I., Golitsyn S.P. and others. Cardiac and endocrine aspects of the use of amiodarone in modern practice in the treatment of cardiac arrhythmias. Moscow.2005.-56 p.
Zhurakulova Zebuniso. (2023). Thyroid and Heart. SCIENTIFIC JOURNAL OF APPLIED AND MEDICAL SCIENCES, 2(5), 243–249. https://www.sciencebox.uz/index.php/amaltibbiyot/article/view/7224
Ahtamovna, ZZ. (2022). Diffusetoxic Goiter, Diagnosis and Treatment. INTERNATIONAL JOURNAL OF HEALTH SYSTEMS AND MEDICAL SCIENCES, 1(6), 331–336.
Zhurakulova Zebuniso Ahtamovna. Secondary infertility in women of reproductive age with hypothyroidism|| ACADEMICIA: An International Multidisciplinary Research Journal|| 2022, Volume: 12, Issue: 5; p: 649-653 ISSN: 2249-7137 DOI: 10.5958/2249-7137.2022.00424.4
ATRIAL FIBRILLATION AND THYROTOXICOSIS KhSh Yakhyaeva, OA Ruziev
TA'LIM VA RIVOJLANISH TAHLILI ONLAYN ILMIY JURNALI 2 (11), 225-234, 2022
Malikovna, AS. (2023). Peculiarities of Thyroid Function in Pregnant Women with Iodine Deficiency. AMALIY VA TIBBIYOT FANLARI ILMIY JURNALI, 2(5), 391–395. Retrieved fromhttps://sciencebox.uz/index.php/amaltibbiyot/article/view/7388
Shodieva Nilufar O'tkirjonovna. (2024). TIREOTOKSIKOZ KASALLIGI KLINIKASINING O'ZIGA XOS JIHATLARI. AMALIY VA TIBBIYOT FANLARI ILMIY JURNALI (https://www.sciencebox.uz/index.php/amaltibbiyot/issue/view/230), 3(3), 112-115.
Ilkhomovich, AN. (2024). THE RELATIONSHIP BETWEEN HYPOTHYROIDISM AND HYPERPROLACTINEMIA. SCIENTIFIC JOURNAL OF APPLIED AND MEDICAL SCIENCES, 3(3), 231–237.
